Legend Biotech (LEGN) News Today $40.14 +1.74 (+4.53%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Legend Biotech Co. (NASDAQ:LEGN) Given Average Recommendation of "Buy" by BrokeragesNovember 20 at 3:35 AM | americanbankingnews.comLegend Biotech Co. (NASDAQ:LEGN) Given Consensus Recommendation of "Buy" by AnalystsShares of Legend Biotech Co. (NASDAQ:LEGN - Get Free Report) have earned an average recommendation of "Buy" from the thirteen research firms that are presently covering the stock, Marketbeat Ratings reports. Thirteen analysts have rated the stock with a buy rating. The average 1-year target priceNovember 20 at 3:32 AM | marketbeat.comCantor Fitzgerald Expects Higher Earnings for Legend BiotechNovember 19 at 2:15 AM | americanbankingnews.comSumitomo Mitsui Trust Group Inc. Boosts Holdings in Legend Biotech Co. (NASDAQ:LEGN)Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 9.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 177,227 shares of the company's stock afNovember 18 at 4:03 AM | marketbeat.comFY2024 EPS Estimate for Legend Biotech Increased by AnalystLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Cantor Fitzgerald lifted their FY2024 earnings estimates for Legend Biotech in a research note issued to investors on Wednesday, November 13th. Cantor Fitzgerald analyst R. Bienkowski now anticipates that the company will post earnings of ($1.50) pNovember 18 at 2:08 AM | marketbeat.comLegend Biotech Corporation (NASDAQ:LEGN) Just Released Its Third-Quarter Earnings: Here's What Analysts ThinkNovember 16, 2024 | finance.yahoo.comMorgan Stanley Remains a Buy on Legend Biotech (LEGN)November 16, 2024 | markets.businessinsider.comBrokers Offer Predictions for Legend Biotech FY2024 EarningsNovember 16, 2024 | americanbankingnews.comLegend Biotech (NASDAQ:LEGN) Hits New 1-Year Low - Should You Sell?Legend Biotech (NASDAQ:LEGN) Sets New 12-Month Low - Should You Sell?November 15, 2024 | marketbeat.comHC Wainwright Predicts Weaker Earnings for Legend BiotechLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Equities research analysts at HC Wainwright reduced their FY2024 earnings estimates for shares of Legend Biotech in a report released on Wednesday, November 13th. HC Wainwright analyst M. Kapoor now forecasts that the company will post earnings ofNovember 15, 2024 | marketbeat.comFY2024 EPS Estimates for Legend Biotech Cut by William BlairLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Investment analysts at William Blair decreased their FY2024 earnings estimates for Legend Biotech in a research note issued to investors on Tuesday, November 12th. William Blair analyst S. Corwin now forecasts that the company will earn ($1.41) perNovember 15, 2024 | marketbeat.comQ2 EPS Estimates for Legend Biotech Lowered by HC WainwrightNovember 15, 2024 | americanbankingnews.comLegend Biotech (LEGN) Gets a Buy from Truist FinancialNovember 14, 2024 | markets.businessinsider.comBuy Rating for Legend Biotech’s CARVYKTI: Strong Market Performance and Future PotentialNovember 14, 2024 | markets.businessinsider.comLegend Biotech Corporation (NASDAQ:LEGN) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | msn.comQ2 EPS Estimates for Legend Biotech Cut by HC WainwrightLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Equities researchers at HC Wainwright reduced their Q2 2025 earnings per share estimates for shares of Legend Biotech in a note issued to investors on Wednesday, November 13th. HC Wainwright analyst M. Kapoor now expects that the company will postNovember 14, 2024 | marketbeat.comLegend Biotech's (LEGN) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $73.00 price target on shares of Legend Biotech in a report on Wednesday.November 13, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Announces Earnings ResultsLegend Biotech (NASDAQ:LEGN - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.56) by $0.22. The business had revenue of $160.20 million during the quarter, compared to the consensus estimate of $143.91 million. Legend Biotech had a negative return on equity of 23.20% and a negative net margin of 62.50%. The business's revenue was up 66.9% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.17) earnings per share.November 13, 2024 | marketbeat.comLegend Biotech Corp (LEGN) Q3 2024 Earnings Call Highlights: CARVYKTI's Impressive Growth Amid ...November 13, 2024 | finance.yahoo.comLegend Biotech (LEGN) Gets a Hold from William BlairNovember 12, 2024 | markets.businessinsider.comLegend Biotech Reports Strong Sales Growth in Q3 2024November 12, 2024 | markets.businessinsider.comLegend Biotech Corporation (LEGN) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comLegend Biotech Corp (LEGN) Q3 2024 Earnings Report Preview: What to Look ForNovember 12, 2024 | finance.yahoo.comLegend Biotech Reports Third Quarter 2024 Results and Recent HighlightsNovember 12, 2024 | markets.businessinsider.comTimesSquare Capital Management LLC Sells 14,336 Shares of Legend Biotech Co. (NASDAQ:LEGN)TimesSquare Capital Management LLC lessened its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 1.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,159,430 shares oNovember 10, 2024 | marketbeat.comLegend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and ExpositionNovember 7, 2024 | globenewswire.comLegend Biotech’s CARVYKTI Shows Promising Myeloma ResultsNovember 7, 2024 | markets.businessinsider.comLegend Biotech (NASDAQ:LEGN) Trading Up 7.7% - Time to Buy?Legend Biotech (NASDAQ:LEGN) Shares Up 7.7% - Here's What HappenedNovember 5, 2024 | marketbeat.comLegend Biotech (LEGN) Scheduled to Post Earnings on TuesdayLegend Biotech (NASDAQ:LEGN) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639702)November 5, 2024 | marketbeat.comLegend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple MyelomaNovember 5, 2024 | globenewswire.comabrdn plc Increases Position in Legend Biotech Co. (NASDAQ:LEGN)abrdn plc lifted its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 110.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 33,729 shares of the company's stock after purchasing an additioNovember 5, 2024 | marketbeat.comLegend Biotech appoints Alan Bash as president of CarvyktiNovember 4, 2024 | markets.businessinsider.comTruist Financial Sticks to Their Buy Rating for Legend Biotech (LEGN)November 4, 2024 | markets.businessinsider.comLegend Biotech Appoints Alan Bash as President of CARVYKTI®November 4, 2024 | globenewswire.comEmpire Life Investments Inc. Purchases 42,368 Shares of Legend Biotech Co. (NASDAQ:LEGN)Empire Life Investments Inc. increased its position in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 75.2% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 98,688 shares of the company's stock after buying an aNovember 3, 2024 | marketbeat.comMirae Asset Global Investments Co. Ltd. Sells 13,151 Shares of Legend Biotech Co. (NASDAQ:LEGN)Mirae Asset Global Investments Co. Ltd. lowered its position in Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 31.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 28,549 shares of thNovember 1, 2024 | marketbeat.comLegend Biotech participates in a conference call with JPMorganOctober 30, 2024 | markets.businessinsider.comRBC Capital Remains a Buy on Legend Biotech (LEGN)October 30, 2024 | markets.businessinsider.comRoyal Bank of Canada Reaffirms Outperform Rating for Legend Biotech (NASDAQ:LEGN)Royal Bank of Canada reissued an "outperform" rating and issued a $86.00 price target on shares of Legend Biotech in a research note on Tuesday.October 29, 2024 | marketbeat.comLegend Biotech Co. (NASDAQ:LEGN) Receives Consensus Recommendation of "Buy" from AnalystsShares of Legend Biotech Co. (NASDAQ:LEGN - Get Free Report) have been given an average recommendation of "Buy" by the fourteen brokerages that are currently covering the stock, MarketBeat Ratings reports. Fourteen equities research analysts have rated the stock with a buy rating. The average 12-mOctober 26, 2024 | marketbeat.comLegend Biotech (NASDAQ:LEGN) Stock Quotes, Forecast and News SummaryOctober 25, 2024 | benzinga.comLegend Biotech to Host Investor Conference Call on Third Quarter 2024 ResultsOctober 24, 2024 | markets.businessinsider.comLegend Biotech (NASDAQ:LEGN) Shares Gap Up - Here's WhyLegend Biotech (NASDAQ:LEGN) Shares Gap Up - Should You Buy?October 22, 2024 | marketbeat.comStrategic Growth and Promising Prospects Drive Buy Rating for Legend BiotechOctober 22, 2024 | markets.businessinsider.comLegend Biotech’s AGM Highlights Shareholder ConfidenceOctober 22, 2024 | markets.businessinsider.comQ3 EPS Estimates for Legend Biotech Boosted by HC WainwrightLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Equities researchers at HC Wainwright lifted their Q3 2024 EPS estimates for Legend Biotech in a note issued to investors on Wednesday, October 16th. HC Wainwright analyst M. Kapoor now forecasts that the company will post earnings per share of ($0October 21, 2024 | marketbeat.comBrokers Set Expectations for Legend Biotech FY2025 EarningsLegend Biotech Co. (NASDAQ:LEGN - Free Report) - Stock analysts at HC Wainwright boosted their FY2025 EPS estimates for shares of Legend Biotech in a report released on Wednesday, October 16th. HC Wainwright analyst M. Kapoor now anticipates that the company will post earnings of $0.12 per shareOctober 18, 2024 | marketbeat.comKrane Funds Advisors LLC Sells 19,045 Shares of Legend Biotech Co. (NASDAQ:LEGN)Krane Funds Advisors LLC cut its stake in shares of Legend Biotech Co. (NASDAQ:LEGN - Free Report) by 95.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 915 shares of the company's stoOctober 18, 2024 | marketbeat.comStrong Q3 Performance and Upcoming Catalysts Drive Buy Rating for Legend BiotechOctober 16, 2024 | markets.businessinsider.comPositive Outlook and Buy Rating for Legend Biotech Driven by CARVYKTI’s Strong Performance and Market EdgeOctober 16, 2024 | markets.businessinsider.com Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! LEGN Media Mentions By Week LEGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LEGN News Sentiment▼0.070.46▲Average Medical News Sentiment LEGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LEGN Articles This Week▼285▲LEGN Articles Average Week Get Legend Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AUTL News BLUE News BNTX News TEVA News BGNE News VTRS News SMMT News MRNA News GMAB News RDY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LEGN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Legend Biotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Legend Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
